scispace - formally typeset
M

Martina Comiskey

Researcher at Beth Israel Deaconess Medical Center

Publications -  9
Citations -  715

Martina Comiskey is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Colitis & T cell. The author has an hindex of 8, co-authored 9 publications receiving 705 citations.

Papers
More filters
Journal ArticleDOI

T Cell–mediated Pathology in Two Models of Experimental Colitis Depends Predominantly on the Interleukin 12/Signal Transducer and Activator of Transcription (Stat)-4 Pathway, but Is Not Conditional on Interferon γ Expression by T Cells

TL;DR: The data suggest that in the models of colitis studied here the effects of IL-12/Stat-4 or other Th1 promoting pathways are not limited to the induction of IFN-γ gene expression in T lymphocytes, and demonstrate that in some forms of chronic experimental colitis the development of pathogenic T cells is influenced predominantly, though not exclusively, by IL- 12.
Journal ArticleDOI

Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis

TL;DR: The LT pathway plays a role in the development of colitis as important as that of the TNF system and, therefore, represents a potential novel intervention point for the treatment of inflammatory bowel disease.
Journal ArticleDOI

Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration

TL;DR: The CD154/CD40 pathway plays a critical role in Th1-induced chronic experimental colitis and blocking CD154, even after the onset of disease, ameliorates colitis but does not induce a T helper 2 (Th2) phenotype.
Journal ArticleDOI

Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin-2 and β2-microglobulin deficient mouse

TL;DR: Molecular genetics, as well as clinical features, of colon cancer in the beta(2)m(null) x IL-2( null) mice are similar to those of human UC- associated colorectal cancer, and this model appears to be an excellent animal model to study UC-associated coloreCTal carcinogenesis.
Journal Article

Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and beta(2)-microglobulin-deficient mouse.

TL;DR: In this article, mutations of Apc and p53 genes and microsatellite instability in colonic adenocarcinomas arising in this model were determined by sequencing in 11 colic adnocarcinsomas.